(¿Â¶óÀÎ) 2021 Á¦ 17Â÷ ´ëÇѹé½ÅÇÐȸ Ãá°èÇмú´ëȸ : 2021-03-26±³À°ÀÏÀÚ : 2021-03-26
±³À°Àå¼Ò : ¿Â¶óÀÎ ±³À°
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ) 2021 Á¦ 17Â÷ ´ëÇѹé½ÅÇÐȸ Ãá°èÇмú´ëȸ ÁÖÃÖ±â°ü : ´ëÇѹé½ÅÇÐȸ
´ã´çÀÚ : ÃÖ¼ö¿¬
¿¬¶ôó : 02-740-8364
À̸ÞÀÏ :
office@korvac.org ±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, »êºÎÀΰú, À̺ñÀÎÈÄ°ú, °¡Á¤ÀÇÇаú¿¹¹æÀÇÇÐ, ºÐÀÚ»ý¹°ÇÐ, ¹Ì»ý¹°ÇÐ,
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 7 ½Ã°£ 50ºÐ
¼¼ºÎ¼ö°·á : 100,000¿ø
ºñ°í ȸ¿ø 1) Àü¹®ÀÇ,¹Ú»ç±Þ ÀÌ»ó ¼±ÀÓ ¹× Ã¥ÀÓ¿¬±¸ÀÚ: »çÀüµî·Ï 5¸¸¿ø/Ãß°¡µî·Ï 7¸¸¿ø 2) Àü°øÀÇ, ´ëÇлý, ´ëÇпø»ý ¹× ¼®»ç±Þ ÀÌÇÏ ¿¬±¸¿ø: »çÀüµî·Ï 3¸¸¿ø/Ãß°¡µî·Ï 5¸¸¿ø ºñȸ¿ø »çÀüµî·Ï 8¸¸¿ø/Ãß°¡µî·Ï 10¸¸¿ø (ÇöÀåµî·Ï ºÒ°¡)
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
ÈÞ½Ä 03¿ù 26ÀÏ ¿Â¶óÀÎ 08:50~09:00 Opening ȲÀÀ¼ö(¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ)
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀÎ 09:00~09:30 COVID-19 global epidemiology – past, present and future prospects Ben Cowling(È«Äá´ë)
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀÎ 09:30~10:00 SARS-CoV-2 mutations and clinical implication ¹Ú¸¸¼º(°í·ÁÀÇ´ë)
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀÎ 10:00~10:30 Treatment strategy based on the pathogenesis of SARS-CoV-2 ±è¼ºÇÑ(¿ï»êÀÇ´ë)
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀÎ 10:30~10:40 Q&A ()
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀÎ 10:40~11:10 Vaccine adjuvants: classification & mode of action À̳ª°æ(¼¼Á¾´ë)
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀÎ 11:10~11:40 Viral vector delivery system ÃÖÁ¤¾Æ(±¹Á¦¹é½Å¿¬±¸¼Ò)
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀÎ 11:40~12:10 Lipid nanoparticle for mRNA vaccine platform ¹æÀº°æ(Çѱ¹°úÇбâ¼ú¿¬±¸¿ø)
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀÎ 12:10~12:20 Q&A ()
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀÎ 12:20~12:45 Rapid Development of a Highly Effective RNA-Based COVID-19 Vaccine Philip R. Dormitzer(Pfizer)
½Ä»ç 03¿ù 26ÀÏ ¿Â¶óÀÎ 12:45~13:20 Lunch ()
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀÎ 13:20~13:50 Efficacy of COVID-19 vaccines ±èÅÂÇü(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀÎ 13:50~14:20 Safety of COVID-19 vaccines Á¤ÈñÁø(°í·ÁÀÇ´ë)
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀÎ 14:20~14:50 Strategies for COVID-19 vaccination: allocation, distribution, and communication È«Á¤ÀÍ(Áúº´°ü¸®Ã»)
Åä·Ð 03¿ù 26ÀÏ ¿Â¶óÀÎ 14:50~15:05 Panel discussion ()
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀÎ 15:05~15:35 Interspecies transmission of zoonotic coronaviruses from SARS to COVID-19 ¼Û´ë¼·(°í·Á´ë ¾àÇдë)
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀÎ 15:35~16:05 SARS-CoV-2 infection in farmed minks - zoonotic concerns °ÇØÀº(³ó¸²Ãà»ê°Ë¿ªº»ºÎ)
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀÎ 16:05~16:15 Q&A ()
ÈÞ½Ä 03¿ù 26ÀÏ ¿Â¶óÀÎ 16:15~16:20 Coffee break ()
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀÎ 16:20~16:50 Influenza, RSV and COVID-19: similar but different diseases ±è¿¹Áø(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀÎ 16:50~17:20 Impacts of the COVID-19 Pandemic on routine pediatric immunization ÃÖ¿µÁØ(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀÎ 17:20~17:30 Q&A ()
ÈÞ½Ä 03¿ù 26ÀÏ 17:30~17:30 Closing ()